This page has moved. Click here to view.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Physicians' Drug Reference

New Warnings. Medical Library. Full Text Journals Medical Books Online. 

Aseptic meningitis outbreak linked to widespread MMR vaccination

 

Her2/Neu vaccination prevents progression of DCIS to invasive cancer in mice

Meningitis C vaccine

Cannabinoids reduce MS symptoms in animal model

Low-dose estrogen plus gestodene or desogestrel provide good cycle control

Zafirlukast effect less marked in elderly asthmatics

ephedra proposal

Hybrid cell vaccination a promising new cancer immunotherapy

HAART use correlates with reductions in HIV-related GI disorders

Salmeterol and fluticasone mixture effective in asthma therapy

Alexion C5 inhibitor gets fast-track status

Solvay gets US approval of testosterone gel

FDA approves new dosage of allergy medication

Sicor antihypertensive approved by FDA

Ariad's graft-versus-host treatment gets orphan drug status

Ivax gets supplemental approval of generic Darvocet-N

Orphan drug status granted to malignant melanoma treatment

Pneumococcal vaccine Prevnar approved for children under 2

FEB 10, 2000 Lotronex (alosetron)

FEB 02, 2000 Protonix (pantoprazole sodium)

 01, 2000 Phenobarbital for cerebral malaria associated with "unacceptable" mortality

FEB 28, 2000 Sumatriptan use linked to preterm delivery

FEB 25, 2000 FDA continues to monitor Rezulin reports

FEB 24, 2000 Fluconazole use in the ICU is associated with negative patient outcomes and unfavorable microbial trends

FEB 21, 2000 Patient prescription misunderstandings arise from lack of participation

FEB 21, 2000 Arthritis is a potential side effect of clopidogrel

FEB 11, 2000 Drug interactions involving St. John's wort reported

FEB 08, 2000 Intranasal beclomethasone dipropionate slows the growth rate of prepubertal children

FEB 14, 2000 Actimmune Injection (interferon gamma-1b) Received orphan-drug approval for the indication of the rare congenital disorder osteopetrosis

FEB 04, 2000 Levaquin (Levofloxacin Tablets/Injection) Approved for the treatment of penicillin-resistant Streptococcus pneumoniae in patients with community acquired pneumonia

DEC 23, 1999 Celebrex (celecoxib) Approved for patients with familial adenomatous polyposis

DEC 23, 1999 Taxotere (docetaxel) Approved for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy.

DEC 15, 1999 Carnitor Injection (levocarnitine) Approved for the treatment of carnitine deficiency in patients with end stage renal disease who are undergoing dialysis

 

DEC 14, 1999 Engerix-B (Hepatitis B Vaccine, Recombinant) Approved for preventing hepatitis B infections which can lead to primary liver cancer

 

DEC 07, 1999 Zoloft (sertraline hydrochloride) Approved for the treatment of post traumatic stress syndrome

 

NOV 29, 1999 Viracept (nelfinavir mesylate) Twice-daily dosing approved by FDA

 

NOV 10, 1999 Remicade (infliximab) Approved for rheumatoid arthritis

 

NOV 03, 1999 Epogen (epoetin alfa) Approved for pediatric use

 

 

 

 03, 2000 Ilex Oncology buys British Biotech's US operations

 

 03, 2000 PathoGenesis, AeroGen to collaborate on cystic fibrosis drug delivery

 

 03, 2000 Hollis-Eden licenses patent series from Humanetics

 

 03, 2000 Mylan settles patent dispute with Pfizer over nifedipine

 

 02, 2000 Chiron gets vaccine patent; stock rises on buy rating

 

 02, 2000 Bioject signs supply deal with Amgen

 

 02, 2000 Isis shares rise on initiation of phase I/II studies of hepatitis C drug

 

 02, 2000 Millennium receives US patent for Melastatin gene

 

 02, 2000 GMP to fund diabetes research efforts

 

 01, 2000 Myogen, UT Southwestern Medical to collaborate on heart failure therapeutics

 

 01, 2000 Cell Pathways, Lilly to study combined anticancer drugs

 

 01, 2000 Isis receives patent on antisense technology

 

 

 

 

JAN 17, 2000 Trileptal (oxcarbazepine) Approved for the treatment of partial seizures in adults and children as young as four years of age

 

DEC 30, 1999 Targretin (bexarotene) Approved for once-daily treatment of cutaneous manifestations of cutaneous T-cell lymphoma

 

DEC 21, 1999 Tequin (gatifloxacin) Indicated for the treatment of infections

 

DEC 13, 1999 Avelox (moxifloxacin HCl) A new quinolone antibiotic

 

DEC 02, 1999 Keppra (Levetiracetam) Approved for adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy

 

NOV 24, 1999 Aggrenox (Aspirin/Extended-Release Dipyridamole) Approved for the prevention of secondary stroke and transient ischemic attacks

 

OCT 28, 1999 Niaspan (niacin) New indication approved for dyslipidemia

 

OCT 25, 1999 Aromasin (exemestane) Approved for the treatment of advanced breast cancer in postmenopausal women

 

OCT 21, 1999 Comtan (entacapone) Approved as an adjunctive treatment for patients with idiopathic Parkinson's disease

 

OCT 06, 1999 Tikosyn (dofetilide) Approved for the maintenance and conversion of normal sinus rhythm in patients with highly symptomatic atrial fibrillation and/or atrial flutter

 

OCT 05, 1999 Rhinocort Aqua nasal spray (budesonide) Approved for the management of nasal symptoms of allergic rhinitis in adults and children six years of age and older

 

OCT 04, 1999 Evista (raloxifene) New indication approved for the treatment of postmenopausal osteoporosis

 

SEP 22, 1999 Accolate (zafirlukast) Approved for asthma therapy in younger children

 

AUG 27, 1999 Repronex (menotropins for SQ injection) Approved for self-administered subcutaneous injection

 

AUG 16, 1999 Cleocin Vaginal Ovules (clindamycin phosphate) Approved for use in non-pregnant women as a 3-day treatment of bacterial vaginosis

 

AUG 13, 1999 Sonata (zaleplon) Approved for insomnia treatment

 

AUG 05, 1999 Zocor (simvastatin) New Indication approved as an adjunct to diet for increasing HDL in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb)

 

JUL 30, 1999 Vestra (reboxetine mesyiate) For use in the treatment of depression

 

JUL 27, 1999 Kytril (granisetron) New indication for nausea in patients undergoing radiation

 

JUL 23, 1999 Topamax (topiramate) As adjunctive therapy in pediatric patients ages 2 - 16 years with partial onset seizures

 

JUL 14, 1999 Plan B (levonorgestrel) The first progestin-only emergency contraceptive pill

 

JUN 29, 1999 Doxil (doxorubicin) Approved for use in women with ovarian cancer refractory to paclitaxel- and platinum-based chemotherapy regimens

 

JUN 11, 1999 Hectorol (doxercalciferol) Approved for the treatment of secondary hyperparathyroidism in patients undergoing chronic renal dialysis

 

APR 01, 1999 Humate-P (Antihemophilic Factor) New Indication in von Willebrand's disease

 

 30, 1999 Sporanox Injection (itraconozole) Approved for several difficult-to-treat, potentially life-threatening fungal infections

 

 26, 1999 NovoSeven (recombinant human coagulation Factor VIIa) Indicated

Her2/Neu vaccination prevents progression of DCIS to invasive cancer in mice

Meningitis C vaccine

Cannabinoids reduce MS symptoms in animal model

Low-dose estrogen plus gestodene or desogestrel provide good cycle control

Zafirlukast effect less marked in elderly asthmatics

ephedra proposal

Hybrid cell vaccination a promising new cancer immunotherapy

HAART use correlates with reductions in HIV-related GI disorders

Salmeterol and fluticasone mixture effective in asthma therapy

Alexion C5 inhibitor gets fast-track status

Solvay gets US approval of testosterone gel

FDA approves new dosage of allergy medication

Sicor antihypertensive approved by FDA

Ariad's graft-versus-host treatment gets orphan drug status

Ivax gets supplemental approval of generic Darvocet-N

Orphan drug status granted to malignant melanoma treatment

Pneumococcal vaccine Prevnar approved for children under 2

FEB 10, 2000 Lotronex (alosetron)

FEB 02, 2000 Protonix (pantoprazole sodium)

  01, 2000 Phenobarbital for cerebral malaria associated with "unacceptable" mortality

FEB 28, 2000 Sumatriptan use linked to preterm delivery

FEB 25, 2000 FDA continues to monitor Rezulin reports

FEB 24, 2000 Fluconazole use in the ICU is associated with negative patient outcomes and unfavorable microbial trends

FEB 21, 2000 Patient prescription misunderstandings arise from lack of participation

FEB 21, 2000 Arthritis is a potential side effect of clopidogrel

FEB 11, 2000 Drug interactions involving St. John's wort reported

FEB 08, 2000 Intranasal beclomethasone dipropionate slows the growth rate of prepubertal children

FEB 14, 2000 Actimmune Injection (interferon gamma-1b) Received orphan-drug approval for the indication of the rare congenital disorder osteopetrosis

FEB 04, 2000 Levaquin (Levofloxacin Tablets/Injection) Approved for the treatment of penicillin-resistant Streptococcus pneumoniae in patients with community acquired pneumonia

DEC 23, 1999 Celebrex (celecoxib) Approved for patients with familial adenomatous polyposis

DEC 23, 1999 Taxotere (docetaxel) Approved for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy.

DEC 15, 1999 Carnitor Injection (levocarnitine) Approved for the treatment of carnitine deficiency in patients with end stage renal disease who are undergoing dialysis

 

DEC 14, 1999 Engerix-B (Hepatitis B Vaccine, Recombinant) Approved for preventing hepatitis B infections which can lead to primary liver cancer

 

DEC 07, 1999 Zoloft (sertraline hydrochloride) Approved for the treatment of post traumatic stress syndrome

 

NOV 29, 1999 Viracept (nelfinavir mesylate) Twice-daily dosing approved by FDA

 

NOV 10, 1999 Remicade (infliximab) Approved for rheumatoid arthritis

 

NOV 03, 1999 Epogen (epoetin alfa) Approved for pediatric use

 

 

 

  03, 2000 Ilex Oncology buys British Biotech's US operations

 

  03, 2000 PathoGenesis, AeroGen to collaborate on cystic fibrosis drug delivery

 

  03, 2000 Hollis-Eden licenses patent series from Humanetics

 

  03, 2000 Mylan settles patent dispute with Pfizer over nifedipine

 

  02, 2000 Chiron gets vaccine patent; stock rises on buy rating

 

  02, 2000 Bioject signs supply deal with Amgen

 

  02, 2000 Isis shares rise on initiation of phase I/II studies of hepatitis C drug

 

  02, 2000 Millennium receives US patent for Melastatin gene

 

  02, 2000 GMP to fund diabetes research efforts

 

  01, 2000 Myogen, UT Southwestern Medical to collaborate on heart failure therapeutics

 

  01, 2000 Cell Pathways, Lilly to study combined anticancer drugs

 

  01, 2000 Isis receives patent on antisense technology

 

 

 

 

JAN 17, 2000 Trileptal (oxcarbazepine) Approved for the treatment of partial seizures in adults and children as young as four years of age

 

DEC 30, 1999 Targretin (bexarotene) Approved for once-daily treatment of cutaneous manifestations of cutaneous T-cell lymphoma

 

DEC 21, 1999 Tequin (gatifloxacin) Indicated for the treatment of infections

 

DEC 13, 1999 Avelox (moxifloxacin HCl) A new quinolone antibiotic

 

DEC 02, 1999 Keppra (Levetiracetam) Approved for adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy

 

NOV 24, 1999 Aggrenox (Aspirin/Extended-Release Dipyridamole) Approved for the prevention of secondary stroke and transient ischemic attacks

 

OCT 28, 1999 Niaspan (niacin) New indication approved for dyslipidemia

 

OCT 25, 1999 Aromasin (exemestane) Approved for the treatment of advanced breast cancer in postmenopausal women

 

OCT 21, 1999 Comtan (entacapone) Approved as an adjunctive treatment for patients with idiopathic Parkinson's disease

 

OCT 06, 1999 Tikosyn (dofetilide) Approved for the maintenance and conversion of normal sinus rhythm in patients with highly symptomatic atrial fibrillation and/or atrial flutter

 

OCT 05, 1999 Rhinocort Aqua nasal spray (budesonide) Approved for the management of nasal symptoms of allergic rhinitis in adults and children six years of age and older

 

OCT 04, 1999 Evista (raloxifene) New indication approved for the treatment of postmenopausal osteoporosis

 

SEP 22, 1999 Accolate (zafirlukast) Approved for asthma therapy in younger children

 

AUG 27, 1999 Repronex (menotropins for SQ injection) Approved for self-administered subcutaneous injection

 

AUG 16, 1999 Cleocin Vaginal Ovules (clindamycin phosphate) Approved for use in non-pregnant women as a 3-day treatment of bacterial vaginosis

 

AUG 13, 1999 Sonata (zaleplon) Approved for insomnia treatment

 

AUG 05, 1999 Zocor (simvastatin) New Indication approved as an adjunct to diet for increasing HDL in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb)

 

JUL 30, 1999 Vestra (reboxetine mesyiate) For use in the treatment of depression

 

JUL 27, 1999 Kytril (granisetron) New indication for nausea in patients undergoing radiation

 

JUL 23, 1999 Topamax (topiramate) As adjunctive therapy in pediatric patients ages 2 - 16 years with partial onset seizures

 

JUL 14, 1999 Plan B (levonorgestrel) The first progestin-only emergency contraceptive pill

 

JUN 29, 1999 Doxil (doxorubicin) Approved for use in women with ovarian cancer refractory to paclitaxel- and platinum-based chemotherapy regimens

 

JUN 11, 1999 Hectorol (doxercalciferol) Approved for the treatment of secondary hyperparathyroidism in patients undergoing chronic renal dialysis

 

APR 01, 1999 Humate-P (Antihemophilic Factor) New Indication in von Willebrand's disease

 

  30, 1999 Sporanox Injection (itraconozole) Approved for several difficult-to-treat, potentially life-threatening fungal infections

 

  26, 1999 NovoSeven (recombinant human coagulation Factor VIIa) Indicated